1. Chronic Myeloid Leukemia: Immunobiology and Novel Immunotherapeutic Approaches

   • Emilie Cayssials
   • Francois Guilhot

   Leading Article 13 May 2017 Pages: 143 - 149

2. Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering

   • Xiaojie Yu
   • Michael J. E. Marshall
   • Max Crispin

   Review Article 02 May 2017 Pages: 151 - 166

   

3. PCSK9 Inhibitors in Hyperlipidemia: Current Status and Clinical Outlook

   • Belinda Di Bartolo
   • Daniel J. Scherer
   • Stephen J. Nicholls

   Review Article 19 April 2017 Pages: 167 - 174

   

4. Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community

   • Richard Markus
   • Jennifer Liu
   • Primal Kaur

   Review Article Open access 24 April 2017 Pages: 175 - 187

   

5. Biosimilars in the United States: Emerging Issues in Litigation

   • Alice Yuen-Ting Wong
   • Martha M. Rumore
   • Albert Wai-Kit Chan

   Review Article 19 April 2017 Pages: 189 - 205

   

6. Interleukin-1 Blockade: An Update on Emerging Indications

   • Anoop Mistry
   • Sinisa Savic
   • Jeroen C. H. van der Hilst

   Review Article 11 May 2017 Pages: 207 - 221

7. Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents

   • Walter Reinisch
   • Jørgen Jahnsen
   • Dae Hyun Yoo

   Original Research Article Open access 11 May 2017 Pages: 223 - 237

   

8. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain

   • Iara DaSilva
   • Ana Huerta
   • Spanish Group for the Study of Glomerular Diseases (GLOSEN)

   Original Research Article 22 May 2017 Pages: 239 - 249

   

9. Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma

   • Caroline Goussen
   • Steve Simoneau
   • Benoît Flan

   Original Research Article Open access 15 May 2017 Pages: 251 - 261

   

10. Golimumab: A Review in Inflammatory Arthritis

    • James E. Frampton

    Adis Drug Evaluation 22 May 2017 Pages: 263 - 274

11. CT-P10 (Truxima™): A Rituximab Biosimilar

    • Emma D. Deeks

    Adis Biosimilar Brief 11 May 2017 Pages: 275 - 278